tiprankstipranks
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
Holding ADAP?
Track your performance easily

Adaptimmune Therapeutics (ADAP) Balance Sheet

812 Followers

Adaptimmune Therapeutics Balance Sheet

Adaptimmune Therapeutics's total assets for Q2 2024 were $321.70M, an increase of 24.69% from the previous quarter. ADAP total liabilities were $225.43M for the fiscal quarter, a -3.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 282.62M$ 328.92M$ 469.55M$ 451.14M$ 181.54M
Total Liabilities
$ 243.10M$ 247.04M$ 263.58M$ 109.92M$ 57.91M
Total Equity Gross Minority
$ 39.51M$ 84.16M$ 205.96M$ 341.23M$ 123.64M
Total Capitalization
$ 59.36M$ 102.23M$ 229.11M$ 362.17M$ 123.64M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Adaptimmune Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis